BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 9356494)

  • 1. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.
    Izumi KM; Kieff ED
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12592-7. PubMed ID: 9356494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
    Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
    J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
    Izumi KM; Cahir McFarland ED; Ting AT; Riley EA; Seed B; Kieff ED
    Mol Cell Biol; 1999 Aug; 19(8):5759-67. PubMed ID: 10409763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
    Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
    PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.
    Izumi KM; Kaye KM; Kieff ED
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1447-52. PubMed ID: 9037073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRADD domain of Epstein-Barr virus transforming protein LMP1 is essential for inducing immortalization and suppressing senescence of primary rodent fibroblasts.
    Xin B; He Z; Yang X; Chan CP; Ng MH; Cao L
    J Virol; 2001 Mar; 75(6):3010-5. PubMed ID: 11222727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
    Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
    Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
    Kaye KM; Izumi KM; Li H; Johannsen E; Davidson D; Longnecker R; Kieff E
    J Virol; 1999 Dec; 73(12):10525-30. PubMed ID: 10559372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.
    Gewurz BE; Mar JC; Padi M; Zhao B; Shinners NP; Takasaki K; Bedoya E; Zou JY; Cahir-McFarland E; Quackenbush J; Kieff E
    J Virol; 2011 Jul; 85(13):6764-73. PubMed ID: 21543491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells.
    Liljeholm S; Hughes K; Grundström T; Brodin P
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2117-25. PubMed ID: 9747720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
    Price AM; Tourigny JP; Forte E; Salinas RE; Dave SS; Luftig MA
    J Virol; 2012 Oct; 86(20):11096-106. PubMed ID: 22855490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.
    Cahir McFarland ED; Izumi KM; Mosialos G
    Oncogene; 1999 Nov; 18(49):6959-64. PubMed ID: 10602470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.
    Ndour PA; Brocqueville G; Ouk TS; Goormachtigh G; Morales O; Mougel A; Bertout J; Melnyk O; Fafeur V; Feuillard J; Coll J; Adriaenssens E
    J Virol; 2012 Apr; 86(7):3934-43. PubMed ID: 22258264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
    Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
    J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMP1 TRAFficking activates growth and survival pathways.
    Soni V; Cahir-McFarland E; Kieff E
    Adv Exp Med Biol; 2007; 597():173-87. PubMed ID: 17633026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation.
    Mitra B; Beri NR; Guo R; Burton EM; Murray-Nerger LA; Gewurz BE
    bioRxiv; 2023 Oct; ():. PubMed ID: 37090591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
    Kilger E; Kieser A; Baumann M; Hammerschmidt W
    EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
    Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
    Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Latent Membrane Protein 1 (LMP1).
    Kieser A; Sterz KR
    Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.